-
Oncocyte Strengthens Transplant Intellectual Property Portfolio with US Patent Covering Digital PCR Technology for Early Detection of Organ Transplant Rejection
27 Oct 2021 12:54 GMT
… --
U.S. patent builds upon prior EU patent protection enabling launch … prior U.S. and EU patents, gives us a protected … States and the European Union (where an earlier patent, EP3004388 was … except as required by law.
Media Contact
Terri Clevenger
Westwicke …
-
UK firms now having to pay £50,000+ ‘security bond’ to litigate in EU post-Brexit
25 Oct 2021 12:58 GMT
… in European countries, according to law firm Mathys & Squire. … the UK Government and the European Union on removing the requirement … intellectual property in the European Union has become a much … of a patent attorney – e.g. through creating inter-EU IP …
-
Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Positive EU CHMP Opinions for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) in Two Different Types of Cancer
18 Oct 2021 00:59 GMT
… as Kisplyx in the European Union [EU] for the treatment of … Private Securities Litigation Reform Act of 1995. These statements … advances, new products and patents attained by competitors; challenges … exposure to litigation, including patent litigation, and/ …
-
Gain Therapeutics, Inc. Announces Appointment of Five Members to its Newly Formed Scientific Advisory Board (SAB)
26 Oct 2021 15:01 GMT
… scientific publications and holds many patents. Dr. Broder was elected … .). Dr. Vellard holds multiple patents and has authored and co … with co-funding from the European Union Horizon 2020 research and … made. Except as required by law, Gain does not undertake …
-
Renalytix Reports Full Year Fiscal 2021 Results
21 Oct 2021 12:37 GMT
… the Private Securities Litigation Reform Act of 1995, as amended … otherwise, except as required by law. INTERIM CHAIRMAN & CEO … completed rights to additional patent applications for use with … in the United States and European Union, Kantaro saw a decrease …
-
FDA expands approval of Dupixent® (dupilumab) to include children aged 6 to 11 years with moderate-to-severe asthma
21 Oct 2021 00:29 GMT
… -severe asthma in the European Union and other health authorities … the Private Securities Litigation Reform Act of 1995, as amended … as required by applicable law, Sanofi does not undertake … (including without limitation the patent litigation and other related …
-
Brazilian Senators back off genocide and homicide charges for Bolsonaro.
20 Oct 2021 23:18 GMT
… , “we won’t hesitate to act.”
Still hoping to avoid that … the European Medicines Agency, the European Union regulator.
Russian authorities have been … in discussions with the Medicines Patent Pool, a nonprofit backed by …
-
FDA Expands Approval of Dupixent(R) (dupilumab) to Include Children Aged 6 to 11 Years with Moderate-to-severe Asthma
20 Oct 2021 22:48 GMT
… -severe asthma in the European Union and other health authorities … (including without limitation the patent litigation and other related … the Private Securities Litigation Reform Act of 1995, as amended … as required by applicable law, Sanofi does not undertake …
-
Unions are divided in response to N.Y.C.’s vaccine mandate for city workers.
20 Oct 2021 19:14 GMT
… European Medicines Agency, the European Union regulator.
Russian authorities have … we won’t hesitate to act.”
Still hoping to avoid … discussions with the Medicines Patent Pool, a nonprofit backed … Better days are ahead.”
Law enforcement officers have tended to …
-
PharmaDrug Commences Trading on the OTCQB Market in the United States
20 Oct 2021 14:05 GMT
… Germany and throughout the European Union. PharmaDrug recently acquired Sairiyo … is currently developing its patented reformulation of cepharanthine, a … "U.S. Securities Act"), or applicable state … required by applicable securities law.
To view the …
About
© 1995-2021